Detalhe da pesquisa
1.
A randomized, double-blind, placebo-controlled trial of aldafermin in patients with NASH and compensated cirrhosis.
Hepatology
; 79(3): 674-689, 2024 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37732990
2.
Performance of Noninvasive Tests of Fibrosis Among Asians, Hispanic, and non-Hispanic Whites in the STELLAR Trials.
Clin Gastroenterol Hepatol
; 21(1): 90-102.e6, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35074532
3.
Efficacy and Safety of Aldafermin, an Engineered FGF19 Analog, in a Randomized, Double-Blind, Placebo-Controlled Trial of Patients With Nonalcoholic Steatohepatitis.
Gastroenterology
; 160(1): 219-231.e1, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32781086
4.
Combination Therapies Including Cilofexor and Firsocostat for Bridging Fibrosis and Cirrhosis Attributable to NASH.
Hepatology
; 73(2): 625-643, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33169409
5.
A Phase 2 Double Blinded, Randomized Controlled Trial of Saroglitazar in Patients With Nonalcoholic Steatohepatitis.
Clin Gastroenterol Hepatol
; 19(12): 2670-2672, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33152542
6.
Role of Noninvasive Tests in Clinical Gastroenterology Practices to Identify Patients With Nonalcoholic Steatohepatitis at High Risk of Adverse Outcomes: Expert Panel Recommendations.
Am J Gastroenterol
; 116(2): 254-262, 2021 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33284184
7.
Safety, Tolerability, and Biologic Activity of AXA1125 and AXA1957 in Subjects With Nonalcoholic Fatty Liver Disease.
Am J Gastroenterol
; 116(12): 2399-2409, 2021 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34382947
8.
Quality of Care Program Reduces Unplanned Health Care Utilization in Patients With Inflammatory Bowel Disease.
Am J Gastroenterol
; 116(12): 2410-2418, 2021 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34797226
9.
Health Economic Impact of a Multicenter Quality-of-Care Initiative for Reducing Unplanned Healthcare Utilization Among Patients With Inflammatory Bowel Disease.
Am J Gastroenterol
; 116(12): 2459-2464, 2021 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34730561
10.
Not Achieving Sustained Viral Eradication of Hepatitis C Virus After Treatment Leads to Worsening Patient-reported Outcomes.
Clin Infect Dis
; 70(4): 628-632, 2020 02 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30949674
11.
A randomized, placebo-controlled trial of emricasan in patients with NASH and F1-F3 fibrosis.
J Hepatol
; 72(5): 816-827, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31887369
12.
Randomized placebo-controlled trial of emricasan for non-alcoholic steatohepatitis-related cirrhosis with severe portal hypertension.
J Hepatol
; 72(5): 885-895, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31870950
13.
Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials.
J Hepatol
; 73(1): 26-39, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32147362
14.
Sofosbuvir, Velpatasvir, and Voxilaprevir for Previously Treated HCV Infection.
N Engl J Med
; 376(22): 2134-2146, 2017 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28564569
15.
Noninvasive Tests Accurately Identify Advanced Fibrosis due to NASH: Baseline Data From the STELLAR Trials.
Hepatology
; 70(5): 1521-1530, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31271665
16.
Ombitasvir/paritaprevir/ritonavir and dasabuvir with or without sofosbuvir for patients with hepatitis C virus genotype 1 infection who failed a prior course of direct-acting antiviral therapy.
J Med Virol
; 91(7): 1307-1312, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30840774
17.
Ribavirin dose management in HCV patients receiving ombitasvir/paritaprevir/ritonavir and dasabuvir with ribavirin.
Liver Int
; 38(9): 1571-1575, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29377566
18.
Ledipasvir and sofosbuvir for previously treated HCV genotype 1 infection.
N Engl J Med
; 370(16): 1483-93, 2014 Apr 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-24725238
19.
ABT-450/r-ombitasvir and dasabuvir with or without ribavirin for HCV.
N Engl J Med
; 370(21): 1983-92, 2014 May 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-24795200
20.
Efficacy of Sofosbuvir, Velpatasvir, and GS-9857 in Patients With Genotype 1 Hepatitis C Virus Infection in an Open-Label, Phase 2 Trial.
Gastroenterology
; 151(5): 893-901.e1, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27486034